Troy E Messick

Vironika, Llc

$3,405,267

Attributed

$4,595,793

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY2009–25

$2M$1.5M$1M$500K$0

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,595,793 · 3

By mechanism

R01$4,327,093 · 2

R43$268,700 · 1

Top collaborators

Paul M. Lieberman3 shared
Pierluigi Porcu3 shared

Most similar at Vironika, Llc

Same institution · by research overlap

Takahiro Yano$1,449,278
Ursula D Ramirez$900,001

Others in their field

Top investigators on “Malignant Neoplasms”

David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Richard K. Wilson · Washington University$274,272,747
Larry Arthur$223,443,122
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879

Research focus

Malignant NeoplasmsHuman Herpesvirus 4Viral GenomeCell GrowthDna BindingPharmaceutical PreparationsViralPropertyNovel Therapeutic InterventionResponseMedicalInhibitorNeoplastic CellInvestigationPathway InteractionsEpstein-Barr Virus-Related Malignant NeoplasmCell SurvivalGene ExpressionCell ProliferationCarcinogenesisChemotherapyImmune FunctionAntineoplastic AgentsEpstein-Barr Virus Latency